Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Research
InPath System developer inks research agreement with University Hospitals of Cleveland
March 9th, 2006
CytoCore, Inc., (MCDG.OB) and the University Hospitals of Cleveland (UHC) announced that CytoCore will be opening a research facility within UHC's Center for Clinical Research. The research at UHC will focus on clinical applications developed at UHC for the identification and treatment of certain gynecological disorders including cervical dysplasia and cervical cancer. These include patented technology developed out of the clinical practice of Dr. George Gorodeski and McDonald Physician's practice group of UHC. CytoCore's CEO, David Weissberg, MD, said: "This new agreement with University Hospitals of Cleveland and its Center for Clinical Research is...
Source: Women's Health Weekly (2006-03-09)
|
